The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
Open accessAbstract
PURPOSE: Radiation dose to the neuroregenerative zone of the hippocampus has been found to be associated with cognitive toxicity. Hippocampal avoidance (HA) using intensity-modulated radiotherapy during whole-brain radiotherapy (WBRT) is hypothesized to preserve cognition. METHODS: This phase III trial enrolled adult patients with brain metastases to HA-WBRT plus memantine or WBRT plus memantine. The primary end point was time to cognitive function failure, defined as decline using the reliable change index on at least one of the cognitive tests. Secondary end points included overall survival (OS), intracranial progression-free survival (PFS), toxicity, and patient-reported symptom burden. RESULTS: Between July 2015 and March 2018, 518 patients were randomly assigned. Median follow-up for alive patients was 7.9 months. Risk of cognitive failure was significantly lower after HA-WBRT plus memantine versus WBRT plus memantine (adjusted hazard ratio, 0.74; 95% CI, 0.58 to 0.95; P = .02). This difference was attributable to less deterioration in executive function at 4 months (23.3% v 40.4%; P = .01) and learning and memory at 6 months (11.5% v 24.7% [ P = .049] and 16.4% v 33.3% [ P = .02], respectively). Treatment arms did not differ significantly in OS, intracranial PFS, or toxicity. At 6 months, using all data, patients who received HA-WBRT plus memantine reported less fatigue ( P = .04), less difficulty with remembering things ( P = .01), and less difficulty with speaking ( P = .049) and using imputed data, less interference of neurologic symptoms in daily activities ( P = .008) and fewer cognitive symptoms ( P = .01). CONCLUSION: HA-WBRT plus memantine better preserves cognitive function and patient-reported symptoms, with no difference in intracranial PFS and OS, and should be considered a standard of care for patients with good performance status who plan to receive WBRT for brain metastases with no metastases in the HA region.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Gaspar, L., Scott, C., Rotman, M., Asbell, S., Phillips, T., Wasserman, T., McKenna, W. G., & Byhardt, R. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,544
Chang, E. L., Wefel, J. S., Hess, K. R., Allen, P. K., Lang, F. F., Kornguth, D. G., Arbuckle, R. B., Swint, J. M., Shiu, A. S., Maor, M. H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70263-3 · Cited by 2,475
Self-citationInflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. (1998) · JAMA · doi:10.1001/jama.280.17.1485 · Cited by 1,915
Brown, P. D., Jaeckle, K., Ballman, K. V., Farace, E., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Barker, F. G., Deming, R., Burri, S. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.9839 · Cited by 1,671
Self-citationSperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0527 · Cited by 1,425 · cited 1×
“To aid in decision making, prognostic systems have been developed to provide survival time estimates for patients with brain metastases.(29) Given the potential for symptoms and impaired function from uncontrolled brain metastases, one of the intents of brain metastases management is palliation through the prevention…”
BackgroundSelf-citationIrradiation induces neural precursor-cell dysfunction
Monje, M. L., Mizumatsu, S., Fike, J. R., & Palmer, T. D. (2002) · Nature Medicine · doi:10.1038/nm749 · Cited by 1,271 · cited 2×
“To our knowledge, this trial provides the first definitive clinical evidence that the hippocampal neuroregenerative niche is important to pathophysiology of RT-induced cognitive decline and builds on extensive preclinical work and prior clinical studies.(9,10,12,13,27,28) This trial’s observation of better preservatio…”
MethodResultGondi, V., Pugh, S. L., Tome, W. A., Caine, C., Corn, B., Kanner, A., Rowley, H., Kundapur, V., DeNittis, A., Greenspoon, J. N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.2909 · Cited by 1,148
Self-citationBrown, P. D., Pugh, S., Laack, N. N., Wefel, J. S., Khuntia, D., Meyers, C., Choucair, A., Fox, S., Suh, J. H., Roberge, D., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not114 · Cited by 958
Self-citationExtreme sensitivity of adult neurogenesis to low doses of X-irradiation.
Mizumatsu, S., Monje, M., Morhardt, D. R., Rola, R., Palmer, T. D., & Fike, J. R. (2003) · PubMed · Cited by 762
Mulvenna, P., Nankivell, M., Barton, R., Faivre-Finn, C., Wilson, P., McColl, E., Moore, B., Brisbane, I., Ardron, D., Holt, T., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30825-x · Cited by 711
The randomization and stratification of patients to clinical trials
Zelen, M. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90015-0 · Cited by 613
Meyers, C. A., Smith, J. A., Bezjak, A., Mehta, M. P., Liebmann, J., Illidge, T., Kunkler, I., Caudrelier, J.-M., Eisenberg, P. D., Meerwaldt, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.128 · Cited by 585
Self-citationWhole-Brain Radiotherapy in the Management of Brain Metastasis
Khuntia, D., Brown, P., Li, J., & Mehta, M. P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6185 · Cited by 466
Self-citationGondi, V., Hermann, B. P., Mehta, M. P., & Tomé, W. A. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.11.031 · Cited by 448
Self-citationWhy avoid the hippocampus? A comprehensive review
Gondi, V., Tomé, W. A., & Mehta, M. P. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.09.013 · Cited by 398
Self-citationGondi, V., Tolakanahalli, R., Mehta, M. P., Tewatia, D., Rowley, H., Kuo, J. S., Khuntia, D., & Tomé, W. A. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.01.039 · Cited by 373
Self-citationRole and Relevance of Neurocognitive Assessment in Clinical Trials of Patients With CNS Tumors
Meyers, C. A., & Brown, P. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6086 · Cited by 349
Self-citationValidation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)
Armstrong, T. S., Mendoza, T., Gring, I., Coco, C., Cohen, M. Z., Eriksen, L., Hsu, M.-A., Gilbert, M. R., & Cleeland, C. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9135-z · Cited by 272
Self-citationRapp, S. R., Case, L. D., Peiffer, A., Naughton, M. M., Chan, M. D., Stieber, V. W., Moore, D. F., Falchuk, S. C., Piephoff, J. V., Edenfield, W. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.4508 · Cited by 270
Whole-Brain Radiotherapy for Brain Metastases: Evolution or Revolution?
Brown, P. D., Ahluwalia, M. S., Khan, O. H., Asher, A. L., Wefel, J. S., & Gondi, V. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.9589 · Cited by 240
Self-citationAoyama, H., Tago, M., & Shirato, H. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1145 · Cited by 220
Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)
Armstrong, T. S., Mendoza, T., Gning, I., Coco, C., Cohen, M. Z., Eriksen, L., Hsu, M.-A., Gilbert, M. R., & Cleeland, C. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9228-8 · Cited by 168
Self-citationMemantine prevents acute radiation-induced toxicities at hippocampal excitatory synapses
Duman, J. G., Dinh, J., Zhou, W. J., Cham, H. X., Mavratsas, V. C., Pavešković, M., Mulherkar, S. A., McGovern, S. L., Tolias, K. F., & Grosshans, D. R. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox203 · Cited by 77
Self-citationSham procedures and the ethics of clinical trials
Miller, F. G., & Kaptchuk, T. J. (2004) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.97.12.576 · Cited by 56
Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception
Winkler, A., & Hermann, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00498 · Cited by 48
Cited by
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Vogelbaum, M. A., Brown, P. D., Messersmith, H., Brastianos, P. K., Burri, S., Cahill, D., Dunn, I. F., Gaspar, L. E., Gatson, N. T. N., Gondi, V., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02314 · Cited by 832
Self-citationLe Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A. S., Metellus, P., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.016 · Cited by 592
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Nabors, L. B., Portnow, J., Ahluwalia, M., Baehring, J., Brem, H., Brem, S., Butowski, N., Campian, J. L., Clark, S. W., Fabiano, A. J., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0052 · Cited by 539
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Wang, K., & Tepper, J. E. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21689 · Cited by 449
Epidemiology of brain metastases and leptomeningeal disease
Lamba, N., Wen, P. Y., & Aizer, A. A. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab101 · Cited by 406
Metadata
- Authors
- Brown, P. D., Gondi, V., Pugh, S., Tome, W. A., Wefel, J. S., Armstrong, T. S., Bovi, J. A., Robinson, C., Konski, A., Khuntia, D., Grosshans, D., Benzinger, T. L. S., Bruner, D., Gilbert, M. R., Roberge, D., Kundapur, V., Devisetty, K., Shah, S., Usuki, K., Anderson, B. M., Stea, B., Yoon, H., Li, J., Laack, N. N., Kruser, T. J., Chmura, S. J., Shi, W., Deshmukh, S., Mehta, M. P., Kachnic, L. A., & Oncology, F. N.
- Venue
- Journal of Clinical Oncology
- Published
- 2020-04-01
- Volume
- 38
- Issue
- 10
- Pages
- 1019-1029
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W3005704292
- Cited by
- 846
- References
- 33
- FWCI
- 61.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.